| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Hearing Loss, Sensorineural | 3 | 2018 | 159 | 0.87 | Why? |
| Paragonimiasis | 1 | 2017 | 6 | 0.71 | Why? |
| Intestinal Diseases, Parasitic | 1 | 2017 | 34 | 0.68 | Why? |
| Colonic Diseases | 1 | 2017 | 96 | 0.61 | Why? |
| Head | 1 | 2017 | 206 | 0.60 | Why? |
| Neck | 1 | 2017 | 307 | 0.57 | Why? |
| Edema | 1 | 2018 | 333 | 0.55 | Why? |
| Plants, Medicinal | 1 | 2018 | 622 | 0.44 | Why? |
| Plant Extracts | 1 | 2018 | 1514 | 0.32 | Why? |
| Hearing Loss, Sudden | 2 | 2018 | 103 | 0.30 | Why? |
| Brain Ischemia | 2 | 2018 | 2813 | 0.30 | Why? |
| Abdominal Pain | 3 | 2021 | 858 | 0.29 | Why? |
| Republic of Korea | 8 | 2021 | 5858 | 0.22 | Why? |
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 6653 | 0.21 | Why? |
| Aquaporin 5 | 1 | 2019 | 13 | 0.21 | Why? |
| Patient Admission | 1 | 2017 | 5250 | 0.21 | Why? |
| Carbonic Anhydrases | 1 | 2019 | 13 | 0.21 | Why? |
| Submandibular Gland | 1 | 2019 | 29 | 0.21 | Why? |
| Genes, src | 1 | 2018 | 3 | 0.19 | Why? |
| src-Family Kinases | 1 | 2018 | 48 | 0.19 | Why? |
| Neurocysticercosis | 1 | 2019 | 51 | 0.19 | Why? |
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2018 | 76 | 0.18 | Why? |
| Oxidopamine | 1 | 2017 | 9 | 0.18 | Why? |
| Coxiella burnetii | 1 | 2019 | 120 | 0.18 | Why? |
| Gerbillinae | 1 | 2017 | 7 | 0.18 | Why? |
| Carbachol | 1 | 2017 | 5 | 0.18 | Why? |
| Sesquiterpenes | 1 | 2018 | 77 | 0.18 | Why? |
| Proto-Oncogene Proteins p21(ras) | 1 | 2018 | 100 | 0.18 | Why? |
| Paragonimus westermani | 1 | 2017 | 2 | 0.18 | Why? |
| Acinar Cells | 1 | 2017 | 14 | 0.18 | Why? |
| Cholesteatoma | 1 | 2017 | 14 | 0.18 | Why? |
| Parasite Egg Count | 1 | 2017 | 14 | 0.18 | Why? |
| Neurotoxicity Syndromes | 1 | 2018 | 124 | 0.18 | Why? |
| Kynurenine | 1 | 2018 | 140 | 0.17 | Why? |
| Phlebotomy | 1 | 2018 | 131 | 0.17 | Why? |
| Flavones | 1 | 2017 | 65 | 0.17 | Why? |
| Stroke | 2 | 2018 | 8839 | 0.17 | Why? |
| Otitis Media with Effusion | 1 | 2017 | 39 | 0.17 | Why? |
| Diverticulitis, Colonic | 1 | 2017 | 38 | 0.17 | Why? |
| Q Fever | 1 | 2019 | 130 | 0.17 | Why? |
| Abdominal Abscess | 1 | 2017 | 41 | 0.17 | Why? |
| Antineoplastic Agents, Phytogenic | 1 | 2018 | 183 | 0.16 | Why? |
| Toxoplasmosis | 1 | 2017 | 59 | 0.16 | Why? |
| Medical Laboratory Personnel | 1 | 2018 | 254 | 0.16 | Why? |
| Guinea Pigs | 1 | 2017 | 420 | 0.16 | Why? |
| Calcium Signaling | 1 | 2017 | 133 | 0.16 | Why? |
| Blood Culture | 1 | 2018 | 308 | 0.16 | Why? |
| Models, Anatomic | 1 | 2017 | 191 | 0.16 | Why? |
| Glioblastoma | 1 | 2018 | 187 | 0.15 | Why? |
| Herpes Zoster | 1 | 2021 | 331 | 0.15 | Why? |
| Apoptosis | 2 | 2018 | 2335 | 0.15 | Why? |
| DNA, Bacterial | 1 | 2019 | 835 | 0.14 | Why? |
| Blood Specimen Collection | 1 | 2018 | 387 | 0.14 | Why? |
| Methicillin-Resistant Staphylococcus aureus | 1 | 2021 | 711 | 0.14 | Why? |
| Nasal Polyps | 1 | 2017 | 221 | 0.14 | Why? |
| Colonic Neoplasms | 1 | 2018 | 295 | 0.14 | Why? |
| Mood Disorders | 1 | 2018 | 431 | 0.13 | Why? |
| Pancreas | 1 | 2017 | 398 | 0.13 | Why? |
| Shock | 1 | 2021 | 1868 | 0.13 | Why? |
| Genes, bcl-2 | 1 | 2012 | 3 | 0.13 | Why? |
| CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2012 | 7 | 0.13 | Why? |
| Species Specificity | 1 | 2017 | 1356 | 0.13 | Why? |
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2012 | 40 | 0.13 | Why? |
| Mice, Inbred C57BL | 3 | 2019 | 5542 | 0.12 | Why? |
| Mice | 5 | 2018 | 21357 | 0.12 | Why? |
| Stomach Neoplasms | 1 | 2018 | 477 | 0.12 | Why? |
| Ethanol | 1 | 2017 | 533 | 0.11 | Why? |
| Brain Neoplasms | 1 | 2018 | 669 | 0.11 | Why? |
| Neurons | 1 | 2017 | 864 | 0.11 | Why? |
| Lymph Nodes | 1 | 2018 | 1060 | 0.11 | Why? |
| Stress, Psychological | 3 | 2020 | 10231 | 0.11 | Why? |
| Depressive Disorder | 2 | 2018 | 1236 | 0.11 | Why? |
| Cats | 1 | 2017 | 1890 | 0.10 | Why? |
| Rhinitis | 1 | 2017 | 626 | 0.10 | Why? |
| Animals | 9 | 2021 | 78931 | 0.10 | Why? |
| Cricetinae | 1 | 2017 | 3344 | 0.10 | Why? |
| Rats | 1 | 2017 | 2764 | 0.10 | Why? |
| Whole Genome Sequencing | 1 | 2020 | 3239 | 0.10 | Why? |
| Immunoglobulins, Intravenous | 1 | 2021 | 2705 | 0.09 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2018 | 2309 | 0.09 | Why? |
| Mycobacterium tuberculosis | 1 | 2018 | 1164 | 0.09 | Why? |
| Immunoglobulin M | 3 | 2021 | 9091 | 0.09 | Why? |
| Male | 19 | 2021 | 367725 | 0.09 | Why? |
| Biopsy | 1 | 2017 | 2811 | 0.09 | Why? |
| Cell Line, Tumor | 4 | 2018 | 3608 | 0.09 | Why? |
| Polymerase Chain Reaction | 2 | 2021 | 6740 | 0.09 | Why? |
| Respiratory System | 1 | 2020 | 3213 | 0.09 | Why? |
| Tuberculosis, Pulmonary | 1 | 2018 | 1171 | 0.09 | Why? |
| Recurrence | 1 | 2017 | 3675 | 0.08 | Why? |
| Carcinoma, Hepatocellular | 1 | 2017 | 1222 | 0.08 | Why? |
| Pharmaceutical Preparations | 1 | 2021 | 1897 | 0.08 | Why? |
| Quality Improvement | 1 | 2018 | 2435 | 0.08 | Why? |
| Genomics | 1 | 2018 | 3118 | 0.08 | Why? |
| Caregivers | 1 | 2020 | 3112 | 0.07 | Why? |
| Parkinson Disease | 1 | 2017 | 1414 | 0.07 | Why? |
| Liver Neoplasms | 1 | 2017 | 1666 | 0.07 | Why? |
| Signal Transduction | 2 | 2018 | 7207 | 0.07 | Why? |
| Adult | 14 | 2021 | 244371 | 0.07 | Why? |
| Fever | 1 | 2021 | 7795 | 0.07 | Why? |
| Immunoglobulin G | 4 | 2021 | 21571 | 0.07 | Why? |
| Adrenal Cortex Hormones | 1 | 2021 | 6537 | 0.07 | Why? |
| Kidney Neoplasms | 1 | 2012 | 832 | 0.07 | Why? |
| Genetic Variation | 1 | 2018 | 3919 | 0.07 | Why? |
| T-Lymphocytes | 1 | 2021 | 6670 | 0.06 | Why? |
| Humans | 28 | 2021 | 930598 | 0.06 | Why? |
| RNA, Viral | 2 | 2021 | 32276 | 0.06 | Why? |
| Viral Load | 2 | 2020 | 15850 | 0.06 | Why? |
| Diagnosis, Differential | 1 | 2017 | 7220 | 0.06 | Why? |
| Cell Survival | 2 | 2018 | 1581 | 0.06 | Why? |
| Antineoplastic Agents | 1 | 2018 | 3550 | 0.06 | Why? |
| Middle Aged | 13 | 2021 | 270681 | 0.06 | Why? |
| Mutation | 2 | 2019 | 12376 | 0.06 | Why? |
| Reactive Oxygen Species | 2 | 2018 | 1136 | 0.06 | Why? |
| Molecular Diagnostic Techniques | 1 | 2018 | 4239 | 0.06 | Why? |
| Phylogeny | 1 | 2020 | 13341 | 0.06 | Why? |
| Ion Transport | 1 | 2019 | 43 | 0.05 | Why? |
| Chemokine CXCL9 | 1 | 2020 | 154 | 0.05 | Why? |
| Enzyme Stability | 1 | 2019 | 72 | 0.05 | Why? |
| Osmolar Concentration | 1 | 2019 | 86 | 0.05 | Why? |
| 3-Hydroxyanthranilate 3,4-Dioxygenase | 1 | 2018 | 1 | 0.05 | Why? |
| Spatial Learning | 1 | 2018 | 7 | 0.05 | Why? |
| Cell Size | 1 | 2019 | 106 | 0.05 | Why? |
| Quinolinic Acid | 1 | 2018 | 11 | 0.05 | Why? |
| Lindera | 1 | 2018 | 2 | 0.05 | Why? |
| Disease Models, Animal | 1 | 2018 | 10998 | 0.05 | Why? |
| Injections, Intraperitoneal | 1 | 2018 | 69 | 0.05 | Why? |
| Gene Expression Regulation, Neoplastic | 2 | 2018 | 1014 | 0.05 | Why? |
| HCT116 Cells | 1 | 2018 | 83 | 0.05 | Why? |
| HT29 Cells | 1 | 2018 | 108 | 0.05 | Why? |
| JNK Mitogen-Activated Protein Kinases | 1 | 2018 | 59 | 0.05 | Why? |
| Herpesvirus 3, Human | 1 | 2021 | 228 | 0.05 | Why? |
| Caspase 3 | 1 | 2018 | 218 | 0.05 | Why? |
| Membrane Transport Proteins | 1 | 2019 | 152 | 0.05 | Why? |
| Restraint, Physical | 1 | 2018 | 74 | 0.05 | Why? |
| Blood Volume | 1 | 2018 | 90 | 0.05 | Why? |
| Genome, Viral | 1 | 2020 | 13157 | 0.04 | Why? |
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2018 | 127 | 0.04 | Why? |
| Mitogen-Activated Protein Kinases | 1 | 2018 | 126 | 0.04 | Why? |
| Retrospective Studies | 6 | 2021 | 105322 | 0.04 | Why? |
| Xenograft Model Antitumor Assays | 1 | 2018 | 274 | 0.04 | Why? |
| DNA Copy Number Variations | 1 | 2018 | 84 | 0.04 | Why? |
| Antibodies, Viral | 2 | 2021 | 51949 | 0.04 | Why? |
| Fluorescent Antibody Technique, Indirect | 1 | 2019 | 393 | 0.04 | Why? |
| Dose-Response Relationship, Drug | 2 | 2017 | 3776 | 0.04 | Why? |
| Poly(ADP-ribose) Polymerases | 1 | 2018 | 91 | 0.04 | Why? |
| Membrane Potential, Mitochondrial | 1 | 2017 | 102 | 0.04 | Why? |
| Female | 13 | 2021 | 380317 | 0.04 | Why? |
| Toxoplasma | 1 | 2017 | 61 | 0.04 | Why? |
| Quinazolines | 1 | 2018 | 126 | 0.04 | Why? |
| Protein-Tyrosine Kinases | 1 | 2018 | 158 | 0.04 | Why? |
| Acute Disease | 2 | 2021 | 6029 | 0.04 | Why? |
| Prognosis | 2 | 2017 | 32490 | 0.04 | Why? |
| Antibodies, Protozoan | 1 | 2017 | 121 | 0.04 | Why? |
| Chemokine CXCL10 | 1 | 2020 | 565 | 0.04 | Why? |
| ErbB Receptors | 1 | 2018 | 320 | 0.04 | Why? |
| Aged | 8 | 2021 | 215776 | 0.04 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.04 | Why? |
| Hydrogen-Ion Concentration | 1 | 2019 | 993 | 0.04 | Why? |
| Whole Exome Sequencing | 1 | 2018 | 437 | 0.04 | Why? |
| Lymphatic Metastasis | 1 | 2018 | 537 | 0.04 | Why? |
| Prospective Studies | 4 | 2021 | 43301 | 0.04 | Why? |
| Antibodies, Bacterial | 1 | 2019 | 510 | 0.04 | Why? |
| Cell Death | 1 | 2017 | 536 | 0.04 | Why? |
| Phosphorylation | 1 | 2018 | 1060 | 0.04 | Why? |
| Cell Membrane | 1 | 2019 | 743 | 0.03 | Why? |
| Caco-2 Cells | 1 | 2018 | 1236 | 0.03 | Why? |
| Sensitivity and Specificity | 3 | 2021 | 22971 | 0.03 | Why? |
| Transfection | 1 | 2017 | 864 | 0.03 | Why? |
| Enzyme-Linked Immunosorbent Assay | 2 | 2021 | 7868 | 0.03 | Why? |
| Antimycin A | 1 | 2012 | 5 | 0.03 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.03 | Why? |
| Drug Resistance, Multiple, Bacterial | 1 | 2021 | 1115 | 0.03 | Why? |
| Kinetics | 1 | 2021 | 3238 | 0.03 | Why? |
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2012 | 47 | 0.03 | Why? |
| Interferon-alpha | 1 | 2020 | 1442 | 0.03 | Why? |
| Molecular Structure | 1 | 2017 | 1539 | 0.03 | Why? |
| Diagnostic Errors | 1 | 2018 | 865 | 0.03 | Why? |
| Interferon-gamma | 1 | 2021 | 2711 | 0.03 | Why? |
| Structure-Activity Relationship | 1 | 2017 | 2219 | 0.03 | Why? |
| Neoplasm Staging | 1 | 2018 | 1999 | 0.03 | Why? |
| DNA, Viral | 1 | 2021 | 2521 | 0.03 | Why? |
| Hospitals, Teaching | 1 | 2018 | 1609 | 0.03 | Why? |
| Rhinitis, Allergic | 1 | 2017 | 704 | 0.03 | Why? |
| Convalescence | 1 | 2021 | 2829 | 0.03 | Why? |
| Nasal Mucosa | 1 | 2017 | 1218 | 0.02 | Why? |
| Bipolar Disorder | 1 | 2018 | 744 | 0.02 | Why? |
| Neoplasm Recurrence, Local | 1 | 2017 | 1063 | 0.02 | Why? |
| Propensity Score | 1 | 2018 | 2690 | 0.02 | Why? |
| Pandemics | 4 | 2020 | 389249 | 0.02 | Why? |
| Hospitals, Pediatric | 1 | 2020 | 1792 | 0.02 | Why? |
| Protein Kinase Inhibitors | 1 | 2018 | 1585 | 0.02 | Why? |
| Asymptomatic Diseases | 1 | 2020 | 3444 | 0.02 | Why? |
| Bacteremia | 1 | 2018 | 1372 | 0.02 | Why? |
| Proteomics | 1 | 2018 | 2481 | 0.02 | Why? |
| New York City | 1 | 2020 | 7432 | 0.02 | Why? |
| Mice, Inbred BALB C | 1 | 2017 | 5814 | 0.02 | Why? |
| Hospitals, University | 1 | 2019 | 4173 | 0.02 | Why? |
| Cells, Cultured | 1 | 2017 | 5835 | 0.02 | Why? |
| HEK293 Cells | 1 | 2019 | 8394 | 0.02 | Why? |
| Phenotype | 1 | 2017 | 4037 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2018 | 6543 | 0.02 | Why? |
| Biomarkers | 2 | 2020 | 23361 | 0.02 | Why? |
| Anxiety Disorders | 1 | 2018 | 2290 | 0.02 | Why? |
| Vero Cells | 1 | 2021 | 14117 | 0.02 | Why? |
| Saliva | 1 | 2021 | 4679 | 0.02 | Why? |
| Diet | 1 | 2017 | 2052 | 0.02 | Why? |
| Up-Regulation | 1 | 2012 | 2249 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2019 | 9537 | 0.02 | Why? |
| Young Adult | 3 | 2020 | 93724 | 0.02 | Why? |
| Logistic Models | 1 | 2018 | 9089 | 0.02 | Why? |
| Chronic Disease | 1 | 2017 | 5139 | 0.02 | Why? |
| Interleukin-6 | 1 | 2020 | 7522 | 0.01 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.01 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.01 | Why? |
| Seroepidemiologic Studies | 1 | 2017 | 10017 | 0.01 | Why? |
| Tertiary Care Centers | 1 | 2018 | 8248 | 0.01 | Why? |
| Risk Factors | 2 | 2021 | 71621 | 0.01 | Why? |
| Sex Factors | 1 | 2017 | 11014 | 0.01 | Why? |
| Prevalence | 1 | 2019 | 25773 | 0.01 | Why? |
| Disease Transmission, Infectious | 1 | 2020 | 9044 | 0.01 | Why? |
| Incidence | 1 | 2018 | 25622 | 0.01 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.01 | Why? |
| Age Factors | 1 | 2017 | 21039 | 0.01 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.01 | Why? |
| Anxiety | 1 | 2020 | 17311 | 0.01 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.01 | Why? |
| Comorbidity | 1 | 2018 | 34796 | 0.01 | Why? |
| Treatment Outcome | 1 | 2017 | 51732 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2020 | 88759 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2017 | 53120 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2017 | 43792 | 0.01 | Why? |
| Child | 1 | 2017 | 70012 | 0.01 | Why? |
| Adolescent | 1 | 2017 | 86841 | 0.00 | Why? |